Perry, Elizabeth <br/><br/>
Clopidogrel hyporesponsiveness and the FDA boxed warning: detection and management of patients with genetic polymorphisms.  [electronic resource] 

 -  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists  Mar 2011 
 - 529-32 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1535-2900 
<br/><br/><label>Standard No.: </label>10.2146/ajhp100422  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aryl Hydrocarbon Hydroxylases--genetics<br/>Clopidogrel<br/>Cytochrome P-450 CYP2C19<br/>Drug Labeling<br/>Genetic Testing<br/>Humans<br/>Platelet Aggregation Inhibitors--pharmacokinetics<br/>Polymorphism, Genetic<br/>Ticlopidine--analogs & derivatives<br/>United States<br/>United States Food and Drug Administration